AFP and neoplasm: In the multivariable analysis, KPS status (P < 0.001, reference KPS I; HR 1.16 [95%CI 1.05–1.28] for KPS II, P = 0.004; HR 1.53 [95%CI 1.26–1.87] for KPS III, P < 0.001), as well as candidate age, candidate race, sum of tumor diameter, pre-transplant AFP, donor ABO blood type, and donor age, was an independent predictor for overall survival (Table 3).